Trametinib Impurity 22
- CAS1044058-33-4
- CatalogueRS-T208094
- FormulaC28H25FIN5O4
- MW641.44
On this page
structure on request
Product identification
| Product name | Trametinib Impurity 22 |
|---|---|
| Catalogue No. | RS-T208094 |
| CAS No. | 1044058-33-4 |
| Molecular formula | C28H25FIN5O4 |
| Molecular weight | 641.44 |
| Exact mass | 641.0935 (monoisotopic) |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Reference Standards |
| Drug substance | Trametinib |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-T208094 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Trametinib
- Standards by type (all categories)
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-T208094
- Request a quotation for RS-T208094
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Trametinib
All 33 further standards are listed here — every link is in the page, not loaded later.
Trametinib
IN STOCKRS-I013168Trametinib Acetate
BACK ORDERRS-T208020Deiodo Trametinib
BACK ORDERRS-I010375Trametinib Dimethyl Sulfoxide
IN STOCKRS-U087053Trametinib Hydroxy Impurity
IN STOCKRS-T208007Trametinib Impurity N2
BACK ORDERRS-T208019Trametinib-13C-d3
BACK ORDERRS-T208014Trametinib Impurity 1
BACK ORDERRS-T208001Trametinib Impurity 3
IN STOCKRS-T208012Trametinib Impurity 9
IN STOCKRS-T208009Trametinib Impurity 10
IN STOCKRS-T208016Trametinib Impurity 19
BACK ORDERRS-I001BBATrametinib Impurity 28
IN STOCKRS-T208013Trametinib Impurity 30
IN STOCKRS-T208004Trametinib Impurity 31
IN STOCKRS-T208021Trametinib Impurity 32
IN STOCKRS-T208005
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.


![Chemical structure of (2S,3S,4S,5R,6S)-6-(2-Amino-4-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid](/structures/w4/IGXOTSIHRCCVJX-ZHOCNHIISA-N.webp?v=11)
![Chemical structure of 1-(3-Amino-4-hydroxyphenyl)-3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethylpyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione](/structures/w4/KYXOFPAKDRWYQM-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl trifluoromethanesulfonate](/structures/w4/MYSICWOANMWNQI-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-1-(3-nitrophenyl)pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione](/structures/w4/VKGYKKVZKDYUBY-UHFFFAOYSA-N.webp?v=11)













